- Home
- BANR vs BHC Comparison
BANR vs BHC Comparison
Compare BANR & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANR | BHC |
|---|---|---|
| Founded | 1890 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | BANR | BHC |
|---|---|---|
| Price | $64.41 | $5.40 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $70.00 | $8.00 |
| AVG Volume (30 Days) | 210.6K | ★ 1.6M |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | 15.57 | ★ 423.08 |
| EPS | ★ 1.60 | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | $0.73 | $4.61 |
| Revenue Next Year | $5.69 | N/A |
| P/E Ratio | $40.48 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $57.05 | $4.41 |
| 52 Week High | $69.83 | $8.69 |
Technical Indicators
Market Signals| Indicator | BANR | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 49.00 | 43.46 |
| Support Level | $63.47 | $4.93 |
| Resistance Level | $64.86 | $5.62 |
| Average True Range (ATR) | 1.55 | 0.25 |
| MACD | -0.32 | -0.03 |
| Stochastic Oscillator | 25.21 | 9.69 |
Price Performance
Historical ComparisonAbout BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho, and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.